GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Assets | ₹18,661 Cr | ₹14,925 Cr | ₹13,309 Cr | ₹17,566 Cr | ₹15,397 Cr |
What is the latest Total Assets ratio of GLENMARK PHARMACEUTICALS ?
| Year | Total Assets |
|---|---|
| Mar2026 | ₹18,661 Cr |
| Mar2025 | ₹14,925 Cr |
| Mar2024 | ₹13,309 Cr |
| Mar2023 | ₹17,566 Cr |
| Mar2022 | ₹15,397 Cr |
How is Total Assets of GLENMARK PHARMACEUTICALS Trending?
| Years | Total Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹18,661 Cr | 25.03 | |
| Mar2025 | ₹14,925 Cr | 12.15 | |
| Mar2024 | ₹13,309 Cr | -24.23 | |
| Mar2023 | ₹17,566 Cr | 14.08 | |
| Mar2022 | ₹15,397 Cr | - | |
Compare Total Assets of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹66,034.8 Cr | 0.3% | -0% | 12.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 0.3% |
-0% |
12.2% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses